Valacyclovir in the treatment of facial herpes simplex virus infection

Journal of Infectious Diseases

Volumn 186, Issue , 2002, Pages S66-S70

  Laiskonis, Alvydas ^a   Thune, T ^b   Neldam, S ^c   Hiltunen Back, E ^d  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Section of General Practice   (Denmark)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VALACICLOVIR;

ADOLESCENT; ADULT; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG CHOICE; DRUG EFFICACY; FACE DISORDER; FEMALE; HEADACHE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0037108628     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343738     Document Type: Article

References (18)

1. Fiddian AP, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J (Clin Res Ed) 1983;286:1699-701.
2. Raborn GW, Martel AY, Grace MGA, McGaw WT. Herpes labialis in skiers. Randomized clinical trial of acyclovir cream versus placebo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:641-5.
3. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R. Boon R. Penciclovir cream for the treatment of herpes simplex labialis: a randomized, multicenter, double-blind, placebo-controlled trial. JAMA 1997;277: 1374-9.
4. Boon R, Goodman JJ, Martinez J, Marks GL, Gamble M. Welch C. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Clin Ther 2000;22:76-90.
5. Spruance SL, Stewart JCB, Rowe NH, McKeough MB, Wenerstrom G. Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990;161:185-90.
6. Spruance SL, Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol 1984;19:675-9.
7. Shaw M, King M. Best JM, Banatvala JE. Gibson JR, Klaber MR. Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J (Clin Res Ed) 1985;291:7-9.
8. Raborn GW, McGaw WT, Grace M, Tyrell LD, Samuels SM. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. J Am Dent Assoc 1987;115:38-42.
9. Gill MJ, Bryant HE, Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand. Antimicrob Agents Chemother 1991;35: 382-3.
10. Meyrick Thomas RH, Dodd HJ, Yeo JM, Kirby JDT. Oral acyclovir in the suppression of recurrent non-genital herpes simplex virus infection. Br J Dermatol 1985;113:731-5.
11. Spruance SL, Hamill ML, Hoge WS, Davis LG, Mills J. Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA 1988;260:1597-9.
12. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis: a double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-72.
13. Spruance SL, Tyring SK, DeGregorio B, Miller C, Beutner K. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996;156:1729-35.
14. Tyring SK, Douglas JM, Corey L, Spruance SL, Esmann J. A randomized, placebo-controlled comparison of oral valaciclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 1998;134:185-91.
15. Strand A, Patel R, Wulf HC, Coates KM, and the International Valaciclovir HSV Study Group. Aborted genital herpes simplex virus lesions: findings from a randomised controlled trial with valaciclovir. Sex Transm Infect (in press).
16. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-62.
17. Richards DM, Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS. Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1983;26:378-438.
18. Spruance SL, Overall JC, Kern ER, et al. The natural history of recurrent herpes simplex labialis. N Engl J Med 1977;297:69-75.